INSERM U861, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases, 91100 Corbeil-Essonnes, France.
Int J Mol Sci. 2023 Oct 18;24(20):15291. doi: 10.3390/ijms242015291.
Over the past 20 years, the use of pluripotent stem cells to mimic the complexities of the human neuromuscular junction has received much attention. Deciphering the key mechanisms underlying the establishment and maturation of this complex synapse has been driven by the dual goals of addressing developmental questions and gaining insight into neuromuscular disorders. This review aims to summarise the evolution and sophistication of in vitro neuromuscular junction models developed from the first differentiation of human embryonic stem cells into motor neurons to recent neuromuscular organoids. We also discuss the potential offered by these models to decipher different neuromuscular diseases characterised by defects in the presynaptic compartment, the neuromuscular junction, and the postsynaptic compartment. Finally, we discuss the emerging field that considers the use of these techniques in drug screening assay and the challenges they will face in the future.
在过去的 20 年中,利用多能干细胞来模拟人类神经肌肉接头的复杂性引起了广泛关注。为了解决发育问题和深入了解神经肌肉疾病,阐明这个复杂突触建立和成熟的关键机制一直是双重目标。本综述旨在总结从人胚胎干细胞分化为运动神经元,到最近的神经肌肉类器官,体外神经肌肉接头模型的发展和完善。我们还讨论了这些模型在破译不同神经肌肉疾病方面的潜力,这些疾病的特征是突触前区、神经肌肉接头和突触后区的缺陷。最后,我们讨论了新兴领域,考虑在药物筛选试验中使用这些技术以及它们未来将面临的挑战。